TGFB1 and neoplasm: In addition, we are currently analyzing if depletion of PAR2 by either siRNA transfection or CRISPR/Cas9 technology can sensitize tumor cells to apoptotic cell death following irradiation and can mimic conventional forms of TGF-β pathway inhibition, e.g., ALK5 kinase inhibition with small molecules.